...
首页> 外文期刊>Molecular and Cellular Biology >Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1α (HNF1α) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1α-Deficient Hepatocytes
【24h】

Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1α (HNF1α) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1α-Deficient Hepatocytes

机译:胚胎而非肝细胞核因子1α(HNF1α)的后表达可以重新激活HNF1α缺陷型肝细胞中的沉默苯丙氨酸羟化酶基因

获取原文

摘要

The failure to transcribe the phenylalanine hydroxylase (PAH) gene in the liver of hepatocyte nuclear factor 1α (HNF1α)-deficient mice correlated with DNA hypermethylation and the presence of an inactive chromatin structure (M. Pontoglio, D. M. Faust, A. Doyen, M. Yaniv, and M. C. Weiss, Mol. Cell. Biol. 17:4948–4956, 1997). To evaluate the precise role played by HNF1α, DNA methylation, or histone acetylation in PAH gene silencing, we examined conditions that could restore PAH gene expression in HNF1α-deficient hepatocytes. We show that reactivation of PAH transcription can be achieved by reexpression of HNF1α in embryonic (i.e., embryonic day 12.5 [e12.5] to e13.5) hepatocytes but not in fetal (e17.5), newborn, and adult HNF1α-deficient hepatocytes. This defines a temporal competence window during which HNF1α can act to (re)program PAH gene transcription. We also show that PAH gene silencing can be partially relieved in HNF1α-deficient hepatocytes by treatment with the demethylating agent 5-azacytidine, even in the absence of HNF1α. Treatment using 5-azacytidine combined with trichostatin, a histone deacetylase inhibitor, resulted in a synergistic reactivation of the silenced PAH gene in adult hepatocytes, but this activity was not further increased by HNF1α reexpression. These results suggest that the HNF1α homeoprotein is involved in stage-specific developmental control of the methylation state and chromatin remodeling of the PAH gene.
机译:未能在肝细胞核因子1α(HNF1α)缺陷型小鼠的肝脏中转录苯丙氨酸羟化酶(PAH)基因与DNA超甲基化和染色质结构失活有关(M. Pontoglio,DM Faust,A.Doyen,M (Yaniv和MC Weiss,分子细胞生物学(Mol.Cell.Biol。)17:4948-4956,1997)。为了评估HNF1α,DNA甲基化或组蛋白乙酰化在PAH基因沉默中发挥的确切作用,我们研究了可以恢复HNF1α缺陷型肝细胞中PAH基因表达的条件。我们显示可以通过在胚胎(即,胚胎第12.5天[e12.5]至e13.5)肝细胞中HNF1α的重新表达而不是在胎儿(e17.5),新生儿和成人HNF1α缺乏的HNF1α的重新表达来实现PAH转录的重新激活肝细胞。这定义了一个时间能力窗口,在此窗口中,HNF1α可以起作用以(重新)编程PAH基因转录。我们还显示,即使在没有HNF1α的情况下,通过用去甲基化剂5-氮杂胞苷处理,在HNF1α缺乏的肝细胞中PAH基因沉默也可以部分缓解。使用5-氮杂胞苷与组蛋白脱乙酰基酶抑制剂曲古抑素联用治疗,可导致成年肝细胞中沉默的PAH基因发生协同激活,但HNF1α的表达并未进一步增强该活性。这些结果表明,HNF1α同源蛋白参与了甲基化状态的阶段特异性发育控制和PAH基因的染色质重塑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号